Oncoarendi Therapeutics LLC

UEI
KKZYNGZDKSC9
CAGE
79GG3
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Oncoarendi Therapeutics LLC's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Myocardin-related transcription factor (mrtf) pathway modulators as a novel, disease-modifying oral medicine for… Grant · R43HL174237 National Heart Lung and Blood Institute $467,769
Potent oral chitotriosidase-1 inhibitors as a novel therapy for sarcoidosis Grant · R43HL144350 National Heart Lung and Blood Institute $237,200
Development of an oral acidic mammalian chitinase inhibitor to treat asthma Grant · R44HL132721 National Heart Lung and Blood Institute $1,730,420

Quick answers

What is Oncoarendi Therapeutics LLC's UEI?

Oncoarendi Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is KKZYNGZDKSC9.

What is Oncoarendi Therapeutics LLC's CAGE code?

Oncoarendi Therapeutics LLC's CAGE code is 79GG3.

Is Oncoarendi Therapeutics LLC registered in SAM.gov?

Oncoarendi Therapeutics LLC's SAM.gov registration expired on December 10, 2025.

What is Oncoarendi Therapeutics LLC's most recent federal award?

Oncoarendi Therapeutics LLC's most recent federal grant award is Myocardin-related transcription factor (mrtf) pathway modulators as a novel, disease-modifying oral medicine for… (R43HL174237), from National Heart Lung and Blood Institute, on May 1, 2024.

On GovTribe

See Oncoarendi Therapeutics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login